New Rasagiline Formulation May Allow Application to Skin

New Rasagiline Formulation May Allow Application to Skin

294256

New Rasagiline Formulation May Allow Application to Skin

A new formulation of rasagiline, approved for Parkinson’s disease, may allow the therapy to be given by applying it to the skin. The treatment’s new formulation was described in the European Journal of Pharmaceutics and Biopharmaceutics, in a study titled “Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson’s therapy.” Rasagiline works by blocking the activity of proteins that normally degrade dopamine in the brain, thus increasing…

You must be logged in to read/download the full post.